Activists Condemn Gilead for Exhorbitant Price of Their New Hepatitis C Drug
For Immediate Release December 9, 2013 Contact: Lynda Dee 410-332-1170 or lyndamdee@aol.com Fair Pricing Coalition Condemns Gilead Sciences on the High Price of New Hepatitis C Drug Sovaldi™, and Urges Rapid and Wide Dissemination of Support Program Details for Uninsured and Underinsured People Living with Hepatitis C The Fair Pricing Coalition (FPC) today condemned Gilead …
Activists Condemn Gilead for Exhorbitant Price of Their New Hepatitis C Drug Read More »